Literature DB >> 11058696

High prevalence of peripheral atherosclerosis in a rapidly developing country.

F Perret1, P Bovet, C Shamlaye, F Paccaud, L Kappenberger.   

Abstract

Cardiovascular disease is rapidly increasing in developing countries experiencing epidemiological transition. We investigated the prevalence of peripheral atherosclerosis in a rapidly developing country and compared our findings with data previously reported in Western populations. A cardiovascular risk factor survey was conducted in 1067 individuals aged 25-64 randomly selected from the general population of Seychelles. High-resolution ultrasonography of the right and left carotid and femoral arteries was performed in a random subgroup of 503 subjects (245 men and 258 women). In each of the four arteries, arterial wall thickness (in plaque-free segments) and atherosclerotic plaques (i.e. focal wall thickening at least 1.0 mm thick) were measured separately. The prevalence of peripheral atherosclerosis was high in this population. For instance, at least one plaque > or =1.0 mm was found in, respectively, 34.9 and 27.5% of men and women aged 25-34 and at least one plaque > or =2.5 mm was found in, respectively, 58.2 and 36.9% of men and women aged 55-64. With reference to data found in the literature, the prevalence of carotid atherosclerosis appeared to be significantly higher in Seychelles than in Western populations. This study provides further evidence for the importance of cardiovascular disease in developing countries. Determinants should be identified and relevant prevention and control programs implemented.

Entities:  

Mesh:

Year:  2000        PMID: 11058696     DOI: 10.1016/s0021-9150(00)00376-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.

Authors:  A R Gilbert; C Pinget; P Bovet; J Cornuz; C Shamlaye; F Paccaud
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

2.  Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population.

Authors:  Patrick Yerly; Nicolas Rodondi; Barathi Viswanathan; Walter Riesen; Pierre Vogt; Pascal Bovet
Journal:  Int J Cardiovasc Imaging       Date:  2012-09-27       Impact factor: 2.357

3.  Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling.

Authors:  Nicolas Baeyens; Mary Jo Mulligan-Kehoe; Federico Corti; David D Simon; Tyler D Ross; John M Rhodes; Thomas Z Wang; Cecile O Mejean; Michael Simons; Jay Humphrey; Martin A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

4.  An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease.

Authors:  Zi Ye; Fara S Kalloo; Angela K Dalenberg; Iftikhar J Kullo
Journal:  Glob Cardiol Sci Pract       Date:  2013-11-01

5.  Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles.

Authors:  Pascal Bovet; Sarah Romain; Conrad Shamlaye; Shanti Mendis; Roger Darioli; Walter Riesen; Luc Tappy; Fred Paccaud
Journal:  Cardiovasc Diabetol       Date:  2009-06-26       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.